StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The significant stock price increase and high trading volume reflect positive market sentiment. Previous FDA approvals often lead to increased investor interest and stock price gains.
What happened, with direct paths to the underlying reporting
SPRC stock up 152.90% on increased volume of 30.86 million shares. SciSparc collaborates with Clearmind on novel binge behavior therapies. Clearmind has filed thirteen related patents globally for the collaboration. FDA approved SPRC's IND for Phase 2b trial on Tourette Syndrome.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.